Target- |
MechanismImmunologic cytotoxicity [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Unknown statusNot Applicable Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer
This study is an open, single infusion, cell infusion dose /method exploration study. In patients with gastric cancer and gastroesophageal cancer without effective treatment, the safety of UCB-NK cell immunotherapy was evaluated and the preliminary curative effect results were obtained.
100 Clinical Results associated with Shandong Jinzhuan Biotechnology Co., Ltd.
0 Patents (Medical) associated with Shandong Jinzhuan Biotechnology Co., Ltd.
100 Deals associated with Shandong Jinzhuan Biotechnology Co., Ltd.
100 Translational Medicine associated with Shandong Jinzhuan Biotechnology Co., Ltd.